ArticleDiscover oncology2026

Pioneering preoperative anti-PD-1 immunotherapy enables curative resection in dMMR advanced/recurrent endometrial carcinoma: a case series (2020-2022).

Huijiao Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.